Lidocaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 02/22/2012. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4904-34
- Dosage Form
- Injection
- Presentation
- Lidocaine Hydrochloride, Injection, 50 mg/5mL (1%,10 mg/1 mL) Syringes (NDC 0409-4904-34)
- Initial Posting
- 02/22/2012
- Revised Date
Reason
Discontinuation of the manufacture of the drug